Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2

Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2

US Patent 10995334 · Granted May 4, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of tumor suppressor gene related diseases by inhibition of natural ant2023
Treatment of tumor suppressor gene related diseases by inhibition of natural ant2023
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2022
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2022
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2022
Treatment of filaggrin (FLG) related diseases by modulation of FLG expression an2022
Treatment of filaggrin (FLG) related diseases by modulation of FLG expression an2022
Treatment of filaggrin (FLG) related diseases by modulation of FLG expression an2022
Treatment of collagen gene related diseases by inhibition of natural antisense t2022
Treatment of collagen gene related diseases by inhibition of natural antisense t2022
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2021
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense 2021